• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

427
72
49
48
24

COUNTRY

47
17
5
5
5

PRICE

21
306
572
1,484

PUBLISHED

21
145
516
1,484

PRODUCT TYPE

1,446
18
15
5

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Smoking Cessation - Pipeline Review, H1 2015

Smoking Cessation - Pipeline Review, H1 2015 Summary This, ‘Smoking Cessation - Pipeline Review, H1 2015’, provides an overview of the Smoking Cessation’s therapeutic pipeline. This report provides...

January 2015
FROM

Alzheimer's Disease - Pipeline Review, H1 2015

Alzheimer's Disease - Pipeline Review, H1 2015 Summary This, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

January 2015
FROM

Acute Pain - Pipeline Review, H1 2015

Acute Pain - Pipeline Review, H1 2015 Summary This, ‘Acute Pain - Pipeline Review, H1 2015’, provides an overview of the Acute Pain’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Degenerative Disc Disease - Pipeline Review, H1 2015

Degenerative Disc Disease - Pipeline Review, H1 2015 Summary This, ‘Degenerative Disc Disease - Pipeline Review, H1 2015’, provides an overview of the Degenerative Disc Disease’s therapeutic pipeline. This...

January 2015
FROM

Memory Impairment - Pipeline Review, H1 2015

Memory Impairment - Pipeline Review, H1 2015 Summary This, ‘Memory Impairment - Pipeline Review, H1 2015’, provides an overview of the Memory Impairment’s therapeutic pipeline. This report provides...

January 2015
FROM

Muscle Spasticity - Pipeline Review, H1 2015

Muscle Spasticity - Pipeline Review, H1 2015 Summary This, ‘Muscle Spasticity - Pipeline Review, H1 2015’, provides an overview of the Muscle Spasticity’s therapeutic pipeline. This report provides...

January 2015
FROM

Tourette Syndrome - Pipeline Review, H1 2015

Tourette Syndrome - Pipeline Review, H1 2015 Summary This, ‘Tourette Syndrome - Pipeline Review, H1 2015’, provides an overview of the Tourette Syndrome’s therapeutic pipeline. This report provides...

January 2015
FROM

Moderate Pain - Pipeline Review, H1 2015

Moderate Pain - Pipeline Review, H1 2015 Summary This, ‘Moderate Pain - Pipeline Review, H1 2015’, provides an overview of the Moderate Pain’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Depression - Pipeline Review, H1 2015

Depression - Pipeline Review, H1 2015 Summary This, ‘Depression - Pipeline Review, H1 2015’, provides an overview of the Depression’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Acute Spinal Cord Injury - Pipeline Review, H1 2015

Acute Spinal Cord Injury - Pipeline Review, H1 2015 Summary This, ‘Acute Spinal Cord Injury - Pipeline Review, H1 2015’, provides an overview of the Acute Spinal Cord Injury’s therapeutic pipeline. This...

January 2015
FROM

Cerebral Palsy - Pipeline Review, H1 2015

Cerebral Palsy - Pipeline Review, H1 2015 Summary This, ‘Cerebral Palsy - Pipeline Review, H1 2015’, provides an overview of the Cerebral Palsy’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Fibromyalgia - Pipeline Review, H1 2015

Fibromyalgia - Pipeline Review, H1 2015 Summary This, ‘Fibromyalgia - Pipeline Review, H1 2015’, provides an overview of the Fibromyalgia’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Eastern Equine Encephalitis - Pipeline Review, H1 2015

Eastern Equine Encephalitis - Pipeline Review, H1 2015 Summary This, ‘Eastern Equine Encephalitis - Pipeline Review, H1 2015’, provides an overview of the Eastern Equine Encephalitis’s therapeutic...

January 2015
FROM

Hyperalgesia - Pipeline Review, H1 2015

Hyperalgesia - Pipeline Review, H1 2015 Summary This, ‘Hyperalgesia - Pipeline Review, H1 2015’, provides an overview of the Hyperalgesia’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Alcohol Addiction - Pipeline Review, H1 2015

Alcohol Addiction - Pipeline Review, H1 2015 Summary This, ‘Alcohol Addiction - Pipeline Review, H1 2015’, provides an overview of the Alcohol Addiction’s therapeutic pipeline. This report provides...

January 2015
FROM

Restless Legs Syndrome - Pipeline Review, H1 2015

Restless Legs Syndrome - Pipeline Review, H1 2015 Summary This, ‘Restless Legs Syndrome - Pipeline Review, H1 2015’, provides an overview of the Restless Legs Syndrome’s therapeutic pipeline. This...

January 2015
FROM

The Older Adult Psychotherapy Treatment Planner, with DSM-5 Updates, 2nd Edition.

This timesaving resource features: - Treatment plan components for 30 behaviorally based presenting problems - Over 1,000 prewritten treatment goals, objectives, and interventions—plus space...

January 2015

Status Epilepticus - Pipeline Review, H1 2015

Status Epilepticus - Pipeline Review, H1 2015 Summary This, ‘Status Epilepticus - Pipeline Review, H1 2015’, provides an overview of the Status Epilepticus’s therapeutic pipeline. This report provides...

January 2015
FROM

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015 Summary This, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015’, provides an overview of the Spinal Muscular Atrophy (SMA)’s therapeutic...

January 2015
FROM

Fatigue - Pipeline Review, H1 2015

Fatigue - Pipeline Review, H1 2015 Summary This, ‘Fatigue - Pipeline Review, H1 2015’, provides an overview of the Fatigue’s therapeutic pipeline. This report provides comprehensive information on...

January 2015
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.